{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:10:46Z","timestamp":1789924246739,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Municipal Natural Science Foundation of China","award":["7212181"],"award-info":[{"award-number":["7212181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The most common progressive form of non-alcoholic fatty liver disease (NAFLD) is non-alcoholic steatohepatitis (NASH), which is characterized by the development of cirrhosis, and requires liver transplantation. We screened for the differentially expressed necroptosis-related genes in NASH in this study, and analyzed immune infiltration through microarray and bioinformatics analysis to identify potential biomarkers, and explore the molecular mechanisms involved in NASH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The GSE24807 microarray dataset of NASH patients and healthy controls was downloaded, and we identified the differentially expressed genes (DEGs). Necroptosis-related differential genes (NRDEGs) were extracted from these DEGs, and functionally annotated by enrichment analyses. The core genes were obtained by constructing gene co-expression networks using weighted gene co-expression network analysis (WGCNA). Finally, the transcription factor (TF) regulatory network and the mRNA-miRNA network were constructed, and the infiltrating immune cell populations were analyzed with CIBERSORT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified six necroptosis-related genes (<jats:italic>CASP1<\/jats:italic>, <jats:italic>GLUL<\/jats:italic>, <jats:italic>PYCARD<\/jats:italic>, <jats:italic>IL33<\/jats:italic>, <jats:italic>SHARPIN,<\/jats:italic> and <jats:italic>IRF9<\/jats:italic>), and they are potential diagnostic biomarkers for NASH. In particular, <jats:italic>PYCARD<\/jats:italic> is a potential biomarker for NAFLD progression. Analyses of immune infiltration showed that M2 macrophages, \u03b3\u03b4 T cells, and T follicular helper cells were associated with the immune microenvironment of NASH, which is possibly regulated by <jats:italic>CASP1<\/jats:italic>, <jats:italic>IL33,<\/jats:italic> and <jats:italic>IRF9<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We identified six necroptosis-related genes in NASH, which are also potential diagnostic biomarkers. Our study provides new insights into the molecular mechanisms and immune microenvironment of NASH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41065-024-00309-z","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:02:09Z","timestamp":1727740929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of necroptosis genes and characterization of immune infiltration in non-alcoholic steatohepatitis"],"prefix":"10.1186","volume":"161","author":[{"given":"Huan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malina","family":"Axinbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1233-1619","authenticated-orcid":false,"given":"Liping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"10290","key":"309_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"7","key":"309_CR2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"309_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"309_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"309_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"issue":"2","key":"309_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","volume":"68","author":"MA Konerman","year":"2018","unstructured":"Konerman MA, Jones JC, Harrison SA. Pharmacotherapy for NASH: current and emerging. J Hepatol. 2018;68(2):362\u201375.","journal-title":"J Hepatol"},{"issue":"12","key":"309_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","volume":"18","author":"M Masoodi","year":"2021","unstructured":"Masoodi M, Gastaldelli A, Hy\u00f6tyl\u00e4inen T, Arretxe E, Alonso C, Gaggini M, et al. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat Rev Gastroenterol Hepatol. 2021;18(12):835\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"309_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4(5):313\u201321.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"309_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","volume":"53","author":"J Seo","year":"2021","unstructured":"Seo J, Nam YW, Kim S, Oh DB, Song J. Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators. Exp Mol Med. 2021;53(6):1007\u201317.","journal-title":"Exp Mol Med"},{"issue":"10","key":"309_CR10","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/thno.54072","volume":"11","author":"C Zhan","year":"2021","unstructured":"Zhan C, Huang M, Yang X, Hou J. MLKL: functions beyond serving as the executioner of necroptosis. Theranostics. 2021;11(10):4759\u201369.","journal-title":"Theranostics"},{"key":"309_CR11","doi-asserted-by":"crossref","unstructured":"Choi ME, Price DR, Ryter SW, Choi AMK. Necroptosis: a crucial pathogenic mediator of human disease. JCI Insight. 2019;4(15):e128834.","DOI":"10.1172\/jci.insight.128834"},{"issue":"1","key":"309_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100.","journal-title":"Mol Cancer"},{"issue":"12","key":"309_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15(12):738\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"309_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.15252\/emmm.201403856","volume":"6","author":"J Gautheron","year":"2014","unstructured":"Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, Koppe C, et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med. 2014;6(8):1062\u201374.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"309_CR15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology. 2013;57(5):1773\u201383.","journal-title":"Hepatology"},{"key":"309_CR16","doi-asserted-by":"publisher","first-page":"726747","DOI":"10.3389\/fimmu.2021.726747","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Lu H, Xiong M. Identifying immune cell infiltration and effective diagnostic biomarkers in rheumatoid arthritis by bioinformatics analysis. Front Immunol. 2021;12:726747.","journal-title":"Front Immunol"},{"key":"309_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fgene.2019.00695","volume":"10","author":"JL Deng","year":"2019","unstructured":"Deng JL, Xu YH, Wang G. Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis. Front Genet. 2019;10:695.","journal-title":"Front Genet"},{"issue":"18","key":"309_CR18","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"key":"309_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics. 2011;12:35.","journal-title":"BMC Bioinformatics"},{"key":"309_CR20","doi-asserted-by":"publisher","first-page":"155444","DOI":"10.1016\/j.cyto.2021.155444","volume":"141","author":"Y Sun","year":"2021","unstructured":"Sun Y, Chen LH, Lu YS, Chu HT, Wu Y, Gao XH, et al. Identification of novel candidate genes in rosacea by bioinformatic methods. Cytokine. 2021;141:155444.","journal-title":"Cytokine"},{"issue":"D1","key":"309_CR21","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-d613.","journal-title":"Nucleic Acids Res"},{"key":"309_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"309_CR23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces MR, Buenrostro JD, Wu B, Greenside PG, Chan SM, Koenig JL, et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat Genet. 2016;48(10):1193\u2013203.","journal-title":"Nat Genet"},{"key":"309_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1198\/000313002533","volume":"56","author":"M Friendly","year":"2002","unstructured":"Friendly M. Corrgrams: exploratory displays for correlation matrices. Am Stat. 2002;56:316\u201324.","journal-title":"Am Stat"},{"issue":"6","key":"309_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919.","journal-title":"Hepatol Int"},{"issue":"6372","key":"309_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992;356(6372):768\u201374.","journal-title":"Nature"},{"issue":"10","key":"309_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.RES.0000166925.45995.ed","volume":"96","author":"FM Syed","year":"2005","unstructured":"Syed FM, Hahn HS, Odley A, Guo Y, Vallejo JG, Lynch RA, et al. Proapoptotic effects of caspase-1\/interleukin-converting enzyme dominate in myocardial ischemia. Circ Res. 2005;96(10):1103\u20139.","journal-title":"Circ Res"},{"issue":"6","key":"309_CR28","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1111\/j.1523-1755.2004.66010.x","volume":"66","author":"S Faubel","year":"2004","unstructured":"Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edelstein CL. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int. 2004;66(6):2202\u201313.","journal-title":"Kidney Int"},{"issue":"1","key":"309_CR29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1038\/s41467-019-09753-2","volume":"10","author":"K Tsuchiya","year":"2019","unstructured":"Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Le Manh T, et al. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun. 2019;10(1):2091.","journal-title":"Nat Commun"},{"issue":"6","key":"309_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.3283","volume":"47","author":"SW Paugh","year":"2015","unstructured":"Paugh SW, Bonten EJ, Savic D, Ramsey LB, Thierfelder WE, Gurung P, et al. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat Genet. 2015;47(6):607\u201314.","journal-title":"Nat Genet"},{"issue":"12","key":"309_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res. 2015;25(12):1285\u201398.","journal-title":"Cell Res"},{"issue":"7784","key":"309_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-019-1752-8","volume":"575","author":"K Newton","year":"2019","unstructured":"Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575(7784):679\u201382.","journal-title":"Nature"},{"key":"309_CR33","doi-asserted-by":"crossref","unstructured":"Muthu M, Kumar R, Syed Khaja AS, Gilthorpe JD, Persson JL, Nordstr\u00f6m A. GLUL ablation can confer drug resistance to cancer cells via a malate-aspartate shuttle-mediated mechanism. Cancers (Basel). 2019;11(12):1945.","DOI":"10.3390\/cancers11121945"},{"key":"309_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2022.05.008","volume":"352","author":"P Sorto","year":"2022","unstructured":"Sorto P, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Saksi J, Nuotio K, Ij\u00e4s P, Tuimala J, et al. Glutamine synthetase in human carotid plaque macrophages associates with features of plaque vulnerability: an immunohistological study. Atherosclerosis. 2022;352:18\u201326.","journal-title":"Atherosclerosis"},{"issue":"2","key":"309_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cmet.2019.11.019","volume":"31","author":"P Petrus","year":"2020","unstructured":"Petrus P, Lecoutre S, Dollet L, Wiel C, Sulen A, Gao H, et al. Glutamine links obesity to inflammation in human white adipose tissue. Cell Metab. 2020;31(2):375-390.e11.","journal-title":"Cell Metab"},{"issue":"1","key":"309_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-018-1580-x","volume":"16","author":"Q Han","year":"2018","unstructured":"Han Q, Ma Y, Wang H, Dai Y, Chen C, Liu Y, et al. Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis. J Transl Med. 2018;16(1):201.","journal-title":"J Transl Med"},{"issue":"1","key":"309_CR37","doi-asserted-by":"publisher","first-page":"22351","DOI":"10.1038\/s41598-021-01465-2","volume":"11","author":"M Koizumi","year":"2021","unstructured":"Koizumi M, Watanabe T, Masumoto J, Sunago K, Imamura Y, Kanemitsu K, et al. Apoptosis-associated speck-like protein containing a CARD regulates the growth of pancreatic ductal adenocarcinoma. Sci Rep. 2021;11(1):22351.","journal-title":"Sci Rep"},{"issue":"24","key":"309_CR38","doi-asserted-by":"publisher","first-page":"21119","DOI":"10.1074\/jbc.C200179200","volume":"277","author":"SM Srinivasula","year":"2002","unstructured":"Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem. 2002;277(24):21119\u201322.","journal-title":"J Biol Chem"},{"issue":"8","key":"309_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"15","author":"BS Franklin","year":"2014","unstructured":"Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, et al. The adaptor ASC has extracellular and \u201cprionoid\u201d activities that propagate inflammation. Nat Immunol. 2014;15(8):727\u201337.","journal-title":"Nat Immunol"},{"issue":"4","key":"309_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/imm.13375","volume":"163","author":"JG de Souza","year":"2021","unstructured":"de Souza JG, Starobinas N, Iba\u00f1ez OCM. Unknown\/enigmatic functions of extracellular ASC. Immunology. 2021;163(4):377\u201388.","journal-title":"Immunology"},{"issue":"7784","key":"309_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, G\u00fcnther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575(7784):683\u20137.","journal-title":"Nature"},{"issue":"11","key":"309_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"309_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/febs.14738","volume":"286","author":"I Shlomovitz","year":"2019","unstructured":"Shlomovitz I, Erlich Z, Speir M, Zargarian S, Baram N, Engler M, et al. Necroptosis directly induces the release of full-length biologically active IL-33 in vitro and in an inflammatory disease model. Febs J. 2019;286(3):507\u201322.","journal-title":"Febs J"},{"issue":"6b","key":"309_CR44","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","volume":"14","author":"P Marvie","year":"2010","unstructured":"Marvie P, Lisbonne M, L\u2019Helgoualc\u2019h A, Rauch M, Turlin B, Preisser L, et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med. 2010;14(6b):1726\u201339.","journal-title":"J Cell Mol Med"},{"key":"309_CR45","first-page":"10","volume":"2019","author":"L Barbier","year":"2014","unstructured":"Barbier L, Ferhat M, Salam\u00e9 E, Robin A, Herbelin A, Gombert JM, et al. Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front Immunol. 2014;2019:10.","journal-title":"Front Immunol"},{"key":"309_CR46","doi-asserted-by":"publisher","first-page":"109414","DOI":"10.1016\/j.biopha.2019.109414","volume":"119","author":"Z Tian","year":"2019","unstructured":"Tian Z, Tang J, Yang Q, Li X, Zhu J, Wu G. Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression. Biomed Pharmacother. 2019;119:109414.","journal-title":"Biomed Pharmacother"},{"issue":"7340","key":"309_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature09816","volume":"471","author":"B Gerlach","year":"2011","unstructured":"Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471(7340):591\u20136.","journal-title":"Nature"},{"key":"309_CR48","doi-asserted-by":"crossref","unstructured":"Fuseya Y, Iwai K. Biochemistry, pathophysiology, and regulation of linear ubiquitination: intricate regulation by coordinated functions of the associated ligase and deubiquitinase. Cells. 2021;10(10):2706.","DOI":"10.3390\/cells10102706"},{"issue":"1","key":"309_CR49","doi-asserted-by":"publisher","first-page":"e29993","DOI":"10.1371\/journal.pone.0029993","volume":"7","author":"S Sieber","year":"2012","unstructured":"Sieber S, Lange N, Kollmorgen G, Erhardt A, Quaas A, Gontarewicz A, et al. Sharpin contributes to TNF\u03b1 dependent NF\u03baB activation and anti-apoptotic signalling in hepatocytes. PLoS ONE. 2012;7(1):e29993.","journal-title":"PLoS ONE"},{"issue":"2","key":"309_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/hep.26368","volume":"58","author":"XA Wang","year":"2013","unstructured":"Wang XA, Zhang R, Jiang D, Deng W, Zhang S, Deng S, et al. Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology. 2013;58(2):603\u201316.","journal-title":"Hepatology"},{"issue":"31","key":"309_CR51","doi-asserted-by":"publisher","first-page":"E3206","DOI":"10.1073\/pnas.1407068111","volume":"111","author":"S McComb","year":"2014","unstructured":"McComb S, Cessford E, Alturki NA, Joseph J, Shutinoski B, Startek JB, et al. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc Natl Acad Sci U S A. 2014;111(31):E3206\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"309_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"S Sutti","year":"2020","unstructured":"Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol. 2020;17(2):81\u201392.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"309_CR53","doi-asserted-by":"publisher","first-page":"e1221557","DOI":"10.1080\/2162402X.2016.1221557","volume":"5","author":"A Ambade","year":"2016","unstructured":"Ambade A, Satishchandran A, Saha B, Gyongyosi B, Lowe P, Kodys K, et al. Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1\u03b1induced IL-10. Oncoimmunology. 2016;5(10):e1221557.","journal-title":"Oncoimmunology"},{"key":"309_CR54","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3389\/fimmu.2018.02389","volume":"9","author":"CM Shiromizu","year":"2018","unstructured":"Shiromizu CM, Jancic CC. \u03b3\u03b4 T lymphocytes: an effector cell in autoimmunity and infection. Front Immunol. 2018;9:2389.","journal-title":"Front Immunol"},{"issue":"1","key":"309_CR55","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41467-018-03493-5","volume":"9","author":"DE Gaddis","year":"2018","unstructured":"Gaddis DE, Padgett LE, Wu R, McSkimming C, Romines V, Taylor AM, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9(1):1095.","journal-title":"Nat Commun"},{"key":"309_CR56","first-page":"9","volume":"2018","author":"L Qin","year":"1884","unstructured":"Qin L, Waseem TC, Sahoo A, Bieerkehazhi S, Zhou H, Galkina EV, et al. Insights into the molecular mechanisms of T follicular helper-mediated immunity and pathology. Front Immunol. 1884;2018:9.","journal-title":"Front Immunol"},{"issue":"8","key":"309_CR57","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s001250051261","volume":"42","author":"AM M\u00f8ller","year":"1999","unstructured":"M\u00f8ller AM, Ek J, Durviaux SM, Urhammer SA, Clausen JO, Eiberg H, et al. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion. Diabetologia. 1999;42(8):1011\u20136.","journal-title":"Diabetologia"},{"key":"309_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tox.2017.11.013","volume":"393","author":"SGJ van Breda","year":"2018","unstructured":"van Breda SGJ, Claessen SMH, van Herwijnen M, Theunissen DHJ, Jennen DGJ, de Kok T, et al. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018;393:160\u201370.","journal-title":"Toxicology"},{"issue":"10","key":"309_CR59","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.V82.10.2998.2998","volume":"82","author":"R Hromas","year":"1993","unstructured":"Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J, et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood. 1993;82(10):2998\u20133004.","journal-title":"Blood"},{"issue":"2","key":"309_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jhep.2020.02.025","volume":"73","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yu J, Wang L, Tang Y, Zhou Q, Ji S, et al. Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. J Hepatol. 2020;73(2):361\u201370.","journal-title":"J Hepatol"},{"issue":"11","key":"309_CR61","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/nar\/19.11.2921","volume":"19","author":"R Lovering","year":"1991","unstructured":"Lovering R, Trowsdale J. A gene encoding 22 highly related zinc fingers is expressed in lymphoid cell lines. Nucleic Acids Res. 1991;19(11):2921\u20138.","journal-title":"Nucleic Acids Res"},{"key":"309_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.02.033","volume":"167","author":"G Fan","year":"2021","unstructured":"Fan G, Zhang C, Wei X, Wei R, Qi Z, Chen K, et al. NEAT1\/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder. Free Radic Biol Med. 2021;167:1\u201311.","journal-title":"Free Radic Biol Med"},{"key":"309_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12885-015-1214-0","volume":"15","author":"G Wu","year":"2015","unstructured":"Wu G, Wang Y, Lu X, He H, Liu H, Meng X, et al. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma. BMC Cancer. 2015;15:182.","journal-title":"BMC Cancer"},{"issue":"8","key":"309_CR64","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/abbs\/gmaa065","volume":"52","author":"M Guo","year":"2020","unstructured":"Guo M, Gan L, Si J, Zhang J, Liu Z, Zhao J, et al. Role of miR-302\/367 cluster in human physiology and pathophysiology. Acta Biochim Biophys Sin (Shanghai). 2020;52(8):791\u2013800.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-024-00309-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-024-00309-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-024-00309-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:03:46Z","timestamp":1727741026000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-024-00309-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s41065-024-00309-z","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}